Previous 10 | Next 10 |
Dogs can be trained to detect more than 90% of COVID-19 infections even when patients are asymptomatic, according to scientists from the London School of Tropical Medicine, Durham University and the group Medical Detection Dogs. Authors of the research, which has yet to be peer-reviewed, hope...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors enter next week prepped for more volatility with risk assets after the cryptocurrency plunge. The negative vib...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Satu...
SOUTH SAN FRANCISCO, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in several u...
Gainers: Sequential Brands (SQBG) +59%.Ferro (FOE) +25%.3D Systems (DDD) +24%.Applied DNA Sciences (APDN) +23%.ShockWave Medical (SWAV) +23%.FutureFuel (FF) +22%.Roblox (RBLX) +16%.Lava Therapeutics (LVTX) +15%.Domtar (UFS) +15%.Fluidigm (FLDM) +15%.Losers: Alset EHome Int...
Gainers: Fluidigm (FLDM) +14%, ShockWave Medical (SWAV) +14%, Precision BioSciences (DTIL) +10%, Ekso Bionics (EKSO) +9%, Cerecor (CERC) +5%.Losers: Larimar Therapeutics (LRMR) -20%, Nano-X Imaging (NNOX) -17%, PMV Pharmaceuticals (P...
Fluidigm Corp. (FLDM) rose 2.8% after a report that activist investor Caligan Partners has accumulated an 11% stake and may ask the company to consider the sale of one of its businesses.Caligan argues that the the company is materially undervalued and that while its mass cytome...
SOUTH SAN FRANCISCO, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will host a virtual investor event that will showcase comp...
The following slide deck was published by Fluidigm Corporation in conjunction with their 2021 Q1 earnings call. For further details see: Fluidigm Corporation 2021 Q1 - Results - Earnings Call Presentation
Fluidigm (FLDM): Q1 Non-GAAP EPS of -$0.15 misses by $0.11; GAAP EPS of -$0.25 misses by $0.11.Revenue of $32.8M (+18.8% Y/Y) beats by $0.83M.Q2 2021 Guidance: Product and service revenue of approximately $29 million to $31 million, or approximately 29 percent to 38 percent year-over-yea...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...